PeptideStack
5.2kquestions
20kanswers
220users

Is 60 mg in 2.5 mL of bacteriostatic water a sensible presentation for oral semaglutide?

Asked 6 Nov 2025Modified 5 months agoViewed 10k times
21

Setup, so nobody has to ask: 60 mg · 2.5 mL · bacteriostatic water · oral semaglutide.

I am trying to build something sustainable rather than something thorough that I will abandon.

I have already decided the broad direction; this is about the specifics.

What should I decide now, and what should I defer?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
bacteriostatic-water
bacteriostatic-water

Water for injection containing roughly 0.9 per cent benzyl alcohol as a bacteriostatic agent. It suppresses growth in a multiple-withdrawal vial;…

149 questions
oral-glp1
oral-glp1

Oral routes for GLP-1 receptor agonism: peptide formulations rescued by absorption enhancers such as SNAC, and true small molecules that need no…

219 questions
shareeditfollowflag
DK
askeddermot_kiely12k166 Nov 2025

5 Answers

Accepted answer first, then by votes
71

Accepted answer

It gives 24 mg/mL, and whether that is sensible depends on the dose you will draw from it. 60 ÷ 2.5 = 24 mg/mL in bacteriostatic water. A 0.5 mg dose is then 2.1 units on a U-100 barrel and a 1 mg dose is 4.2 units. The smaller dose lands too low on the scale to read accurately — more diluent would buy resolution you cannot recover later.

The honest answer is that a wide range of volumes works and that the extremes at either end cause avoidable problems.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

Specifically, worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.

Nothing here is medical advice, and research-use material is not approved for human use.

Measure a volume you can actually measure. Round numbers, real syringes.

shareimprove this answerflag
BB
answered · acceptedbac_or_bust33k13730 Jan 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
27

The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.

Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.

Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Concentration equals content over volume, and content is not label claim.

edited 6 Mar 2026 by Dr_Jonas_Halvorsen — clarified the distinction between purity and content

shareimprove this answerflag
DH
answeredDr_Jonas_Halvorsen28k3710 Feb 2026
22

This is the one decision in the whole preparation sequence that cannot be revised later, which is why it is worth thirty seconds of arithmetic.

For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

Write the concentration on the label at reconstitution, in units per dose.

shareimprove this answerflag
GW
answeredgel_pack_warm13k2722 Feb 2026
17

Aim for a dose volume somewhere between about 10 and 30 units on a U-100 barrel and the reading problem disappears.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

Do not change the diluent volume between vials of a titration without recalculating; it is the commonest source of a ten-fold error.

Check the vial can physically hold the volume before you draw it up.

shareimprove this answerflag
UM
answeredu100_marks52k375 Mar 2026
6Adding a vote because this deserves more of them. – laminar_bench 3 months ago
add a comment
16

Answering this needs the syringe you actually own, because the barrel graduations decide what "readable" means.

Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

The caveat is that this arithmetic assumes the vial contains what the label says, and without a content assay it is precise about an unknown quantity.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

edited 5 Jan 2026 by triple_agonist_q — expanded the table to cover the lower concentration

shareimprove this answerflag
TQ
answeredtriple_agonist_q57k3817 Dec 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.